Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often experience therapy resistance leading to low long-term survival rates, with only 7.2% of patients surviving beyond […]

$100 million comprehensive research and patient care center will offer the latest advancing therapies for dementia and all neurologic disorders Amid a rising tsunami of needed care for dementia and other neurologic diseases, construction began this week on the $100 million Center for Brain Health, a new patient care and clinical trials facility of The […]

This spring, UT Health San Antonio announced it will build a $100 million Center for Brain Health to enhance its Biggs Institute and the Department of Neurology of its Joe R. and Teresa Lozano Long School of Medicine.

Doctoral student’s research suggests difficulty of translating longevity interventions from lower species to mammals If a drug extends the life span of worms or flies, is it likely to do the same in mice? Michael Bene, PhD student Not typically based on the existing data, said Michael Bene, a sixth-year doctoral student at The University […]

Protection is afforded infants against disease-causing bacteria Certain immune cells possess a homing property that directs them to the skin at birth to protect the baby, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovered. “These T cells home in on the skin like a guided missile,” […]